The Union health ministry said the case fatality ratio for the age group over 45 was 2.85 per cent.
The government has shown grave concern over the rise in cases in some states, taking India towards a second wave. In some of these states, the pace of vaccination has also been slow.
Also Read
V K Paul, member-health, NITI Aayog, also stressed that there was no signal for thrombosis or blood clotting in the use of Covishield in the country.
“Advisory has gone from WHO that Covishield is safe. There is no risk of blood clotting-related complications suspected in some nations.”
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)